ORIGINAL RESEARCH
Accepted on 30 Oct 2025
Study on mechanism of action of β-elemene in inhibiting cisplatin resistance in lung cancer through LncRNA LINC00511
- 101 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- The Molecular Mechanism in Anti-tumor Therapy Resistance
The Molecular Mechanism in Anti-tumor Therapy Resistance
11k
Total downloads
46k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 25 Jul 2025
Targeting PGK1 as a Novel strategy to regulate the sensitivity of HER2 positive gastric cancer to lapatinib
doi 10.3389/fphar.2025.1530492
- 851 views
ORIGINAL RESEARCH
Published on 23 Jul 2025
Phosphoglycerate kinase 1 as a potential prognostic biomarker in papillary thyroid carcinoma
doi 10.3389/fphar.2025.1542159
- 886 views
ORIGINAL RESEARCH
Published on 04 Apr 2025
MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study
doi 10.3389/fphar.2025.1465814
- 1,878 views
- 1 citation
CASE REPORT
Published on 10 Mar 2025
Case Report: A novel MET exon 14 skipping mutation after EGFR-TKI resistance in advanced lung adenocarcinoma and sustained clinical response to savolitinib
doi 10.3389/fphar.2025.1489696
- 1,538 views
REVIEW
Published on 26 Feb 2025
Mitochondria-associated non-coding RNAs and their impact on drug resistance
doi 10.3389/fphar.2025.1472804
- 1,697 views
- 1 citation
CASE REPORT
Published on 20 Feb 2025
Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report
doi 10.3389/fphar.2025.1431422
- 1,039 views
REVIEW
Published on 15 Jan 2025
The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
doi 10.3389/fphar.2024.1437022
- 2,797 views
- 1 citation
ORIGINAL RESEARCH
Published on 18 Dec 2024
Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC
doi 10.3389/fphar.2024.1464852
- 2,442 views
- 2 citations
REVIEW
Published on 25 Nov 2024
Long noncoding RNA mediates enzalutamide resistance and transformation in neuroendocrine prostate cancer
doi 10.3389/fonc.2024.1481777
- 1,868 views
- 1 citation
REVIEW
Published on 16 Sep 2024
HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future
doi 10.3389/fphar.2024.1446414
- 6,086 views
- 15 citations
REVIEW
Published on 06 Sep 2024
Strategies for engineering oncolytic viruses to enhance cancer immunotherapy
doi 10.3389/fphar.2024.1450203
- 2,733 views
- 8 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore